Mark Milton

Mark Milton

Company: Novartis

Job title: Ophthalmology Therapeutic Area Head, PK Sciences

Seminars:

Q&A Panel Discussion: Ethics & Trial Design 2:55 pm

• Enrolment criteria for pre-existing immunity titer and how this shifts from company to company • Forward thinking drug development trial design with the patient in mind • How has COVID-19 affected gene therapy trials? What can be learned from this for future trial design?Read more

day: Day Two

Clinical Trial Enrolment for Rare Disease Populations & Clinical Endpoints 2:15 pm

• What level of pre-existing immunity is accepted? • What level of protein expression is sufficient for different indications? • What safety biomarkers do you use to understand pathology in man?Read more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.